NCT03612791 2026-04-03
ATEZOLACC
Gustave Roussy, Cancer Campus, Grand Paris
Phase 2 Completed
Clinical Trials
5 trialsNCT06079671 2026-04-02
eVOLVECervical
AstraZeneca
Phase 3 Recruiting
NCT07450963 2026-03-05
Cadonilimab Combined With RT in LACC Patients Ineligible for CCRT
Ruijin Hospital
Phase 2 Not yet recruiting
NCT07435987 2026-02-27
ARCHITECT
Erasmus Medical Center
Phase NA Not yet recruiting
NCT06943833 2026-01-20
IVOLGA
AstraZeneca
Phase 2 Active not recruiting